Analysts’ Viewpoint on Nanotechnology Drug Delivery Market Scenario
The global nanotechnology drug delivery market is expected to witness tremendous growth opportunities due to rising incidences of oncology and chronic disorders across the globe. Companies in the global nanotechnology drug delivery market are gaining lucrative revenue opportunities due to a large number of ongoing clinical trials, outsourcing services, research activities, and increase in healthcare investment by governments. However, high cost of medicines and stringent regulations associated with nanotechnology drug delivery are some of the factors expected to impact the growth of the global nanotechnology drug delivery market during the forecast period.
The nanotechnology drug delivery market is significantly driven by factors such as increasing awareness among the people about nanotechnology, rapidly increasing incidences of chronic illnesses, technological advancement, and rising investment in nanotechnology by government in several developing countries. Due to rising demand for novel drug delivery, manufacturers are gaining lucrative growth opportunities in the global market. Nanotechnology drug delivery is an expanding area of the healthcare industry, and is witnessing increasing acceptance in medical and healthcare applications.
The nanotechnology drug delivery system is used in neurology, anti-infective, cardiovascular disorders, and others. The system also has an application in transporting drugs to the final location of therapeutic intervention within the body. The nanotechnology drug delivery market is witnessing rapid growth due to increase in R&D activities in nanotechnology to develop novel nano-medicine. Various organic and inorganic nanomaterials have been utilized for DDS applications. The term nano pharmaceuticals cover different nano-based DDS that can be used to encapsulate drugs for better targeting than with conventional drugs.
To know the scope of our report Get a Sample on Nanotechnology Drug Delivery Market
There is a flourishing growth of pharmaceutical companies across the globe. Rising investment in R&D activities in drug development and discovery is contributing to expansion of the nanotechnology drug delivery market. The global pharmaceutical industry has been developing compounds for over a century. Many of these never reached the market. The acceptance of new drug formulations is expensive and slow process. It takes so many years to obtain accreditation of new drug formulas with no guarantee of success. Antineoplastic agents are highly effective in cancer treatment. However, it leads to chronic side effects due to cytotoxic properties and lack of target specificity. Hence, pharmaceutical companies are developing innovative drug delivery systems in order to increase target specificity for the cytotoxic drugs that are already present in the market.
Get a glimpse of the in-depth analysis through our Report Brochure
The global nanotechnology drug delivery market has been classified into nanocrystals, liposomes, micelles, nanoparticles, nanotubes, etc. There has been a major role of a technology in the delivery of medicine to measure the size of the particles in nanometer ranges. The rising acceptance of nanotechnology-based drug delivery systems for both doctors and patients is due to lower drug toxicity, more specific targeting, and reduced cost of treatment. Nowadays, several drug entities fail clinical trials, as the compound is incapable to reach the targeted site without exhibiting any side effects. The delivery of a compound to specific target site is the most important part of any treatment ranging from infections to cancer. The overall drug consumption and side effects can be reduced with the help of the nanotechnology drug delivery system.
The nanotechnology drug delivery system is used in the field of neurology, oncology, cardiovascular/physiology, anti-inflammatory/immunology, anti-infective, and others. Oncology is the largest segment of the global market and expected to witness lucrative growth potential in the upcoming years due to rising cancer cases across the globe.
Expanding operations in future? To get the perfect launch ask for a custom report
North America is expected to account for a major market share of the global nanotechnology drug delivery market. Some of the key factors responsible for the market growth are well-established healthcare infrastructure and increase in number of biopharmaceutical companies in the region. The increasing prevalence chronic diseases all over the world demand technologically advanced drug delivery systems. Asia Pacific and Latin America are other attractive markets, which are poised to rise due to the increasing healthcare spending and improving healthcare facilities. This is due to economic growth, rise in spending capacity, surge in prevalence of cancers, and improvement in healthcare infrastructure.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 77.1 Bn |
|
Market Forecast Value in 2028 |
US$ 142.8 Bn |
|
Growth Rate (CAGR) |
7.9 % |
|
Forecast Period |
2017–2028 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Nanotechnology Drug Delivery Market – Segmentation
TMR’s study on the global nanotechnology drug delivery market includes information divided into three segments: technology, application, and region. Changing industry trends and other market dynamics associated with these segments of the global nanotechnology drug delivery market are discussed in detail.
| Technology |
|
| Application |
|
| Region |
|
Nanotechnology drug delivery market is expected to cross the value of US$ 142.8 Bn by the end of 2028
Nanotechnology drug delivery market is estimated to expand at a CAGR of 7.9% from 2021 to 2028
The nanotechnology drug delivery market is driven increasing awareness among the people about nanotechnology and rapidly increasing incidences of chronic illnesses
North America is more attractive for vendors in the nanotechnology drug delivery market
Key players in the global nanotechnology drug delivery market include AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nanotechnology Drug Delivery Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nanotechnology Drug Delivery Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. Covid-19 Impact Analysis
6. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Technology, 2017–2028
6.3.1. Nanocrystals
6.3.2. Nanoparticles
6.3.2.1. Dendrimers
6.3.2.2. Gold Nanoparticles
6.3.2.3. Fullerenes
6.3.2.4. Others
6.3.3. Liposomes
6.3.4. Micelles
6.3.5. Nanotubes
6.3.6. Others
6.4. Market Attractiveness Analysis, by Technology
7. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by Application, 2017–2028
7.3.1. Neurology
7.3.2. Oncology
7.3.3. Cardiovascular/Physiology
7.3.4. Anti-inflammatory/Immunology
7.3.5. Anti-infective
7.3.6. Others (hematology, ophthalmology, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value & Volume Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Nanotechnology Drug Delivery Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Technology, 2017–2028
9.2.1. Nanocrystals
9.2.2. Nanoparticles
9.2.2.1. Dendrimers
9.2.2.2. Gold Nanoparticles
9.2.2.3. Fullerenes
9.2.2.4. Others
9.2.3. Liposomes
9.2.4. Micelles
9.2.5. Nanotubes
9.2.6. Others
9.3. Market Value & Volume Forecast, by Application, 2017–2028
9.3.1. Neurology
9.3.2. Oncology
9.3.3. Cardiovascular/Physiology
9.3.4. Anti-inflammatory/Immunology
9.3.5. Anti-infective
9.3.6. Others (hematology, ophthalmology, etc.)
9.4. Market Value & Volume Forecast, by Country, 2017–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Technology
9.5.2. By Application
9.5.3. By Country
10. Europe Nanotechnology Drug Delivery Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Technology, 2017–2028
10.2.1. Nanocrystals
10.2.2. Nanoparticles
10.2.2.1. Dendrimers
10.2.2.2. Gold Nanoparticles
10.2.2.3. Fullerenes
10.2.2.4. Others
10.2.3. Liposomes
10.2.4. Micelles
10.2.5. Nanotubes
10.2.6. Others
10.3. Market Value & Volume Forecast, by Application, 2017–2028
10.3.1. Neurology
10.3.2. Oncology
10.3.3. Cardiovascular/Physiology
10.3.4. Anti-inflammatory/Immunology
10.3.5. Anti-infective
10.3.6. Others (hematology, ophthalmology, etc.)
10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Technology
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Nanotechnology Drug Delivery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Technology, 2017–2028
11.2.1. Nanocrystals
11.2.2. Nanoparticles
11.2.2.1. Dendrimers
11.2.2.2. Gold Nanoparticles
11.2.2.3. Fullerenes
11.2.2.4. Others
11.2.3. Liposomes
11.2.4. Micelles
11.2.5. Nanotubes
11.2.6. Others
11.3. Market Value & Volume Forecast, by Application, 2017–2028
11.3.1. Neurology
11.3.2. Oncology
11.3.3. Cardiovascular/Physiology
11.3.4. Anti-inflammatory/Immunology
11.3.5. Anti-infective
11.3.6. Others (hematology, ophthalmology, etc.)
11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Technology
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Nanotechnology Drug Delivery Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Technology, 2017–2028
12.2.1. Nanocrystals
12.2.2. Nanoparticles
12.2.2.1. Dendrimers
12.2.2.2. Gold Nanoparticles
12.2.2.3. Fullerenes
12.2.2.4. Others
12.2.3. Liposomes
12.2.4. Micelles
12.2.5. Nanotubes
12.2.6. Others
12.3. Market Value & Volume Forecast, by Application, 2017–2028
12.3.1. Neurology
12.3.2. Oncology
12.3.3. Cardiovascular/Physiology
12.3.4. Anti-inflammatory/Immunology
12.3.5. Anti-infective
12.3.6. Others (hematology, ophthalmology, etc.)
12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Technology
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Nanotechnology Drug Delivery Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Technology, 2017–2028
13.2.1. Nanocrystals
13.2.2. Nanoparticles
13.2.2.1. Dendrimers
13.2.2.2. Gold Nanoparticles
13.2.2.3. Fullerenes
13.2.2.4. Others
13.2.3. Liposomes
13.2.4. Micelles
13.2.5. Nanotubes
13.2.6. Others
13.3. Market Value & Volume Forecast, by Application, 2017–2028
13.3.1. Neurology
13.3.2. Oncology
13.3.3. Cardiovascular/Physiology
13.3.4. Anti-inflammatory/Immunology
13.3.5. Anti-infective
13.3.6. Others (hematology, ophthalmology, etc.)
13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Technology
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Market Footprint Analysis
14.3.1. By Region
14.3.2. By Technology
14.3.3. By Application
14.4. Competitive Business Strategies
14.5. Company Profiles
14.5.1. AbbVie, Inc.
14.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.1.2. Product Portfolio
14.5.1.3. SWOT Analysis
14.5.1.4. Strategic Overview
14.5.2. Amgen, Inc.
14.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.2.2. Product Portfolio
14.5.2.3. SWOT Analysis
14.5.2.4. Strategic Overview
14.5.3. Celgene Corporation
14.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.3.2. Product Portfolio
14.5.3.3. SWOT Analysis
14.5.3.4. Strategic Overview
14.5.4. Johnson & Johnson
14.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.4.2. Product Portfolio
14.5.4.3. SWOT Analysis
14.5.4.4. Strategic Overview
14.5.5. Merck & Co., Inc.
14.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.5.2. Product Portfolio
14.5.5.3. SWOT Analysis
14.5.5.4. Strategic Overview
14.5.6. Perrigo Company plc
14.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.6.2. Product Portfolio
14.5.6.3. SWOT Analysis
14.5.6.4. Strategic Overview
14.5.7. Pfizer, Inc.
14.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.7.2. Product Portfolio
14.5.7.3. SWOT Analysis
14.5.7.4. Strategic Overview
14.5.8. Teva Pharmaceutical Industries Ltd.
14.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.8.2. Product Portfolio
14.5.8.3. SWOT Analysis
14.5.8.4. Strategic Overview
14.5.9. Other players
List of Table
Table 01: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028
Table 02: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028
Table 03: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Region, 2021–2028
Table 04: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028
Table 05: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country, 2021–2028
Table 06: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028
Table 07: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028
Table 08: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028
Table 09: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2021–2028
Table 10: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028
Table 11: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028
Table 12: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2021–2028
Table 13: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2017–2028
Table 14: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028
Table 15: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017–2028
Table 16: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2017–2028
Table 17: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028
Table 18: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017–2028
List of Figures
Figure 01: Global Nanotechnology Drug Delivery Market Snapshot
Figure 02: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2017–2028
Figure 03: Market Value Share, by Technology, 2020
Figure 04: Market Value Share, by Application, 2020
Figure 05: Market Value Share, by Region, 2020
Figure 06: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028
Figure 07: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanocrystals, 2017–2028
Figure 08: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanoparticles, 2017–2028
Figure 09: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Liposomes, 2017–2028
Figure 10: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Micelles, 2017–2028
Figure 11: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanotubes, 2017–2028
Figure 12: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028
Figure 13: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Neurology, 2017–2028
Figure 14: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Oncology, 2017–2028
Figure 15: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Cardiovascular/Physiology, 2017–2028
Figure 16: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Anti-inflammatory/Immunology, 2017–2028
Figure 17: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Anti-infective, 2017–2028
Figure 18: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Region, 2020 and 2028
Figure 19: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, by Region
Figure 20: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2021–2028
Figure 21: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country, 2020 and 2018
Figure 22: North America Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028
Figure 23: North America Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028
Figure 24: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2021–2028
Figure 25: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region
Figure 26: Europe Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028
Figure 27: Europe Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028
Figure 28: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017– 2027
Figure 29: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 30: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028
Figure 31: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028
Figure 32: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
Figure 33: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2021–2028
Figure 34: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028
Figure 35: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028
Figure 36: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2017–2028
Figure 37: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region
Figure 38: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028
Figure 39: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028
Figure 40: Global Nanotechnology Drug Delivery Market Share Analysis, by Company (2020)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Nanotechnology Drug Delivery Market
